PIWIL3

PIWIL3 is an Argonaute/PIWI-subfamily protein that functions as a piRNA-guided regulator of transposable elements and gene expression during mammalian oogenesis and early embryogenesis. In oocytes, PIWIL3 binds ~18-nucleotide piRNAs—the predominant small non-coding RNA class in human female germ cells—and localizes to mitochondria as part of a trimeric complex with TDRKH and PNLDC1, whose assembly requires N-terminal arginines of PIWIL3 (PMID:32486081). PIWIL3-bound piRNAs broadly suppress transposable elements (LINE-1, ERVs) during oogenesis, and CRISPR knockout in rabbit demonstrates that PIWIL3 is essential for piRNA biogenesis, transposon silencing, and maternal-effect progression past the 8-cell stage [PMID:bio_10.1101_2025.10.23.684072, PMID:bio_10.1101_2025.07.22.666229]. In somatic cancer contexts, PIWIL3 engages piRNA-mediated RNA targeting—binding piR-30188 to regulate the OIP5-AS1/miR-367-3p/CEBPA axis in glioma—and modulates JAK2/STAT3 signaling in gastric cancer cells (PMID:29464001, PMID:28869440).

1. 2008 Low

   Initial detection of PIWIL3 protein in human tumor tissues established that this germ-line-associated PIWI protein is expressed in somatic cancers, raising the question of what functional role it plays outside the germline.

   Evidence Immunohistochemistry with validated polyclonal antibodies on human glioma and meningioma tissue biochips

   PMID:18616918

   Open questions at the time

   • No functional data; expression detection only without knockdown or mechanistic follow-up
   • Antibody specificity not confirmed by knockout control
   • No piRNA profiling performed
2. 2017 Medium

   Two independent studies began to define PIWIL3's somatic functions: identification as a direct binding target of the RNAi-activating drug enoxacin suggested PIWIL3 modulates small RNA pathways in cancer cells, while knockdown in gastric cancer cells revealed PIWIL3 promotes proliferation, migration, and invasion upstream of JAK2/STAT3 phosphorylation.

   Evidence Click-chemistry/quantitative mass spectrometry target identification (enoxacin); siRNA knockdown with proliferation, invasion assays, and Western blot for JAK2/STAT3 phosphorylation in gastric cancer cells and xenografts

   PMID:28094937 PMID:28869440

   Open questions at the time

   • Enoxacin binding site on PIWIL3 and downstream consequence not mapped
   • JAK2/STAT3 activation mechanism (direct vs. indirect) unresolved
   • No piRNA partner identified in gastric cancer context
3. 2018 Medium

   The discovery that PIWIL3 binds piR-30188 to target the lncRNA OIP5-AS1, feeding into a miR-367-3p/CEBPA transcriptional feedback loop in glioma, provided the first piRNA-guided target-recognition mechanism for PIWIL3 in a somatic setting.

   Evidence RNA immunoprecipitation, luciferase reporter assays, siRNA/overexpression perturbations, and in vivo xenograft in glioma cells

   PMID:29464001

   Open questions at the time

   • Direct cleavage of OIP5-AS1 by PIWIL3/piR-30188 not demonstrated biochemically
   • Feedback loop validated in a single glioma cell line
   • Relationship between this axis and JAK2/STAT3 signaling unknown
4. 2020 High

   Demonstrating the native germline context, PIWIL3 was shown to localize to mitochondria in oocytes and assemble into a trimeric piRNA-processing complex with TDRKH and PNLDC1 via its N-terminal arginines, with ~50% of complex-bound piRNAs mapping to transposable elements—establishing the biochemical basis for its genome defense role.

   Evidence Co-immunoprecipitation, immunolocalization, N-terminal arginine mutagenesis, and piRNA sequencing in bovine oocytes

   PMID:32486081

   Open questions at the time

   • Catalytic slicer activity of PIWIL3 in this complex not directly tested
   • Structural basis of TDRKH/PNLDC1 recognition of PIWIL3 N-terminal arginines unknown
   • Whether the same trimeric complex forms in human oocytes not shown
5. 2025 Medium

   Genetic loss-of-function and single-oocyte profiling studies converged to establish PIWIL3 as essential for piRNA biogenesis, transposon silencing, and oocyte-to-embryo transition: rabbit CRISPR knockout caused oogenesis defects and 8-cell embryonic arrest with derepressed transposons, while human oocyte sequencing showed PIWIL3-bound ~18 nt piRNAs are the dominant small RNAs that suppress LINE-1 and ERVs during oogenesis.

   Evidence CRISPR-Cas9 knockout in rabbit with small RNA-seq, transcriptomics, proteomics (preprint); single-oocyte simultaneous small/long RNA sequencing across four human developmental stages (preprint)

   PMID:bio_10.1101_2025.07.22.666229 PMID:bio_10.1101_2025.10.23.684072

   Open questions at the time

   • Both studies are preprints awaiting peer review
   • Human genetic loss-of-function data for PIWIL3 not yet available
   • Mechanism by which PIWIL3 switches from transposon repression to activation in early embryogenesis unclear

• Key unresolved questions include whether PIWIL3 possesses endonucleolytic slicer activity in vivo, how the PIWIL3/TDRKH/PNLDC1 complex coordinates piRNA 3′-end trimming, whether PIWIL3 loss in humans causes infertility, and the physiological relevance of PIWIL3 re-expression in somatic cancers.
• No biochemical reconstitution of PIWIL3 slicer or piRNA-trimming activity
• No human genetic study linking PIWIL3 mutations to reproductive phenotypes
• Structural model of PIWIL3-piRNA complex absent